Abstract
This chapter deals with the metabolic and endocrine disorders that affect the skeleton in childhood. It also considers the results of excess and deficiency of vitamins and the toxic effects of metals on bone. These disorders deal with inherited conditions, such as osteopetrosis, that result from abnormal bone cell biology; with polyostotic fibrous dysplasia, in which endocrine disturbances may also occur; and with ossification in the soft tissues, particularly when this is inherited. Osteogenesis imperfecta—an important metabolic disorder that has become a subject of its own [1]—and the skeletal dysplasias are dealt with in Chapter 7. The prevalence of individual metabolic bone diseases varies with age; in particular osteoporosis, so frequent in adult life, is rare in childhood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004; 363:1377–85.
Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, Regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005; 16:3251–63.
Cohen MM. The new bone biology: pathologic, molecular and clinical correlates. Am J Med Genetics 2006; 140A:2646–706.
Smith R, Wordsworth P. Clinical and biochemical disorders of the skeleton. Oxford: Oxford University Press; 2006.
McKusick VA, Amberger JS. Morbid anatomy of the human genome. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Principles and Practice of Medical Genetics, 4th ed. London: Churchill Livingstone; 2002:175–298.
Johnson ML, Harnish K, Nusse R, Van Hul W. LRP5 and Wnt signaling; a union made for bone. J Bone Miner Res 2004; 19:1749–57.
Bilezikian J, Raisz L, Rodan G. Principles of Bone Biology, 2nd ed. San Diego CA: Academic Press; 2002.
Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. New Engl J Med 2004; 351:2839–49.
Quarles LD. Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest 2003; 112:642–6.
Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metabol 2007; 3:122–33.
Adams JS, Hewison M. Unexpected actions of Vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metabol 2008; 4:80–90.
Holick MF. Vitamin D deficiency. New Engl J Med 2007; 357:266–81.
Wharton B, Bishop N. Rickets. Lancet 2003; 362:1389–400.
Whyte MP. Rickets and osteomalacia (acquired and heritable forms). In: Wass JAH, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. Oxford: Oxford University Press; 2002:697–715.
Gahl WA, Thoere J, Scheider JA. Cystinosis. New Engl J Med 2002; 347:111–21.
Smith R. Biochemical Disorders of the Skeleton. London: Butterworths; 1979.
Smith R. Idiopathic juvenile osteoporosis; experience of twenty-one patients. Br J Rheumatol 1995; 34:68–77.
Brumsen C, Hamdy NAT, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Medicine 1997; 76:266–83.
Whyte MP. Heritable forms of rickets and osteomalacia. In: Royce PM, Steinmann B, eds. Connective Tissue and its Heritable Disorders, 2nd ed. New York: Wiley-Liss; 2002:849–99.
Cundy T, Davidson J, Rutland MD, et al. Recombinant osteoprotegerin for juvenile Paget’s disease. New Engl J Med 2005; 353:918–23.
Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genetics 2006; 38:525–7.
Smith R. Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease. Clin Orthop Rel Res 1998; 346:7–14.
Weinstein RS. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res 1997; 12:1314–15.
Langman CB. Hypercalcemic syndromes in infants and children. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Nineral Metabolism, 3rd ed. Philadelphia PA: Lippincott-Raven; 1996:209–12.
Marsden PA. Increased body lead burden—cause or consequence of chronic renal insufficiency. New Engl J Med 2003; 348:345–7.
Whyte MP, Essinger K, Gannon FH, et al. Skeletal fluorosis and instant tea. Am J Med 2005; 118:78–82.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Smith, R. (2010). Metabolic and Endocrine Disorders of the Skeleton. In: Benson, M., Fixsen, J., Macnicol, M., Parsch, K. (eds) Children's Orthopaedics and Fractures. Springer, London. https://doi.org/10.1007/978-1-84882-611-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-84882-611-3_8
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-610-6
Online ISBN: 978-1-84882-611-3
eBook Packages: MedicineMedicine (R0)